<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001402'>Hepatocellular carcinoma</z:hpo> (<z:mp ids='MP_0003331'>HCC</z:mp>), a disease with poor survival rates unless recognized and treated early, ranks as the fifth most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> worldwide and has a rising incidence in the United States </plain></SENT>
<SENT sid="1" pm="."><plain>Recent data indicate that the growing epidemic of type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> may contribute to this alarming trend </plain></SENT>
<SENT sid="2" pm="."><plain>In this issue, Lai et al. utilize a large Taiwanese insurance claims database to demonstrate that <z:mp ids='MP_0002055'>diabetes</z:mp> is associated with an increased risk of <z:mp ids='MP_0003331'>HCC</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Moreover, this risk escalates if <z:mp ids='MP_0002055'>diabetes</z:mp> coincides with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C and <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Lai et al. also show that treatment with <z:chebi fb="0" ids="6801">metformin</z:chebi> or <z:chebi fb="0" ids="50864">thiazolidinediones</z:chebi> may reduce the risk of <z:mp ids='MP_0003331'>HCC</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>The findings may prompt risk stratification for <z:mp ids='MP_0003331'>HCC</z:mp> surveillance and improved disease control in <z:mp ids='MP_0002055'>diabetes</z:mp> as measures of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prevention </plain></SENT>
</text></document>